Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5554-3.
Published January 18, 2017 · Recall initiated: August 22, 2016
Summary
FDA records drug Class II recall D-0429-2017, published January 18, 2017 and initiated August 22, 2016. Recalling firm: Noven Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 364,830 patches; Lot: Lot #: 79230, Exp. 02/2017; 77547, Exp.07/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.
What to do
Voluntary: Firm initiated · Letter
Get an email if DAYTRANA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DAYTRANA
- Manufacturer
- Noven Pharmaceuticals, Inc.
- Distributor
- Nationwide within the US
- Lot
- Lot #: 79230, Exp. 02/2017; 77547, Exp.07/2016
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADaytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) Transdermal Patch, 10 mg over 9 hours (1.1mg/hr), packaged in-January 18, 2017
- FDADaytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged inJanuary 18, 2017
Questions about this recall
Was Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5554-3. recalled?
Yes. FDA published recall D-0429-2017 on January 18, 2017. Reported hazard: Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DAYTRANA.